153 related articles for article (PubMed ID: 18478927)
1. [Correlation of expression of RhoC with invasiveness of breast cancer cells in vitro].
Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):898-903. PubMed ID: 18478927
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro].
Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):51-5. PubMed ID: 18346381
[TBL] [Abstract][Full Text] [Related]
3. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
4. [Expression of RhoC and ROCK-1 and their effects on MAPK and Akt proteins in prostate carcinoma].
Bu Q; Tang HM; Tan J; Hu X; Wang DW
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):202-6. PubMed ID: 21575520
[TBL] [Abstract][Full Text] [Related]
5. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
6. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
7. RhoC is essential for the metastasis of gastric cancer.
Liu N; Zhang G; Bi F; Pan Y; Xue Y; Shi Y; Yao L; Zhao L; Zheng Y; Fan D
J Mol Med (Berl); 2007 Oct; 85(10):1149-56. PubMed ID: 17549441
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
[TBL] [Abstract][Full Text] [Related]
10. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
[TBL] [Abstract][Full Text] [Related]
11. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
Liu Z; Zhu J; Cao H; Ren H; Fang X
Int J Oncol; 2012 May; 40(5):1553-60. PubMed ID: 22293682
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.
Joglekar M; Elbezanti WO; Weitzman MD; Lehman HL; van Golen KL
J Cell Biochem; 2015 Jun; 116(6):923-33. PubMed ID: 25559359
[TBL] [Abstract][Full Text] [Related]
13. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
14. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
[TBL] [Abstract][Full Text] [Related]
15. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.
Kleer CG; van Golen KL; Zhang Y; Wu ZF; Rubin MA; Merajver SD
Am J Pathol; 2002 Feb; 160(2):579-84. PubMed ID: 11839578
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.
Li DQ; Hou YF; Wu J; Chen Y; Lu JS; Di GH; Ou ZL; Shen ZZ; Ding J; Shao ZM
Eur J Cancer; 2006 Dec; 42(18):3274-86. PubMed ID: 16979889
[TBL] [Abstract][Full Text] [Related]
17. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
[TBL] [Abstract][Full Text] [Related]
18. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.
Kleer CG; Zhang Y; Pan Q; Gallagher G; Wu M; Wu ZF; Merajver SD
Breast Cancer Res; 2004; 6(1):R110-5. PubMed ID: 14696649
[TBL] [Abstract][Full Text] [Related]
19. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
[TBL] [Abstract][Full Text] [Related]
20. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
